OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced that its ORAcollect®·RNA saliva collection device has been included in the U.S. Food and Drug Administration Emergency Use Authorization granted to Quadrant Biosciences Inc. for a COVID-19 laboratory test.
September 24, 2020
· 8 min read